DMK Pharmaceuticals's total assets for Q3 2023 were $8.96M, an increase of 88.61% from the previous quarter. DMKPQ total liabilities were $14.25M for the fiscal quarter, a -12.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.